论文部分内容阅读
目的:探讨血清孕酮(P)+β-人绒毛膜促性腺激素(β-HCG)和孕酮联合检测对异位妊娠(EP)早期诊断的临床意义。方法:回顾性分析2006~2010年本院EP疑似患者82例(其中P+β-HCG组43例,β-HCG组39例)的临床资料,并进行统计学分析。结果:P+β-HCG组诊断EP的初诊与确诊符合率显著提高,确诊时间亦显著提早(P<0.05);EP病例血清孕酮、β-HCG值明显低于宫内妊娠病例(P<0.01)。结论:血清孕酮与β-HCG联合测定是早期诊断EP的首选方法,为患者赢得了治疗时机,对预后监测具有积极的临床应用价值,值得临床广泛应用。
Objective: To investigate the clinical significance of serum progesterone (P) + β-human chorionic gonadotropin (β-HCG) and progesterone in the early diagnosis of ectopic pregnancy (EP). Methods: The clinical data of 82 patients with suspected EP in our hospital from 2006 to 2010 (including 43 in P + β-HCG group and 39 in β-HCG group) were retrospectively analyzed and statistically analyzed. Results: The coincidence rate of newly diagnosed and diagnosed EP in P + β-HCG group was significantly increased, and the definite diagnosis time was significantly earlier (P <0.05). The serum progesterone and β-HCG levels in EP patients were significantly lower than those in intrauterine pregnancy (P < 0.01). Conclusion: The combination of serum progesterone and β-HCG is the first choice for the early diagnosis of EP. It has won the treatment opportunity for patients and has positive clinical value for prognosis monitoring. It is worthy of clinical application.